Project Grant U01GH000518

The National Institute of Child Health and Human Development (NICHD) awarded the University of Washington $985,308 under the Child Health and Human Development Extramural Research program (CFDA 93.865) beginning September 1, 2025, and concluding May 31, 2030. This Project Grant funds research to advance pharmacy-based delivery of primary sexually transmitted infection (STI) and HIV prevention interventions for cisgender adolescent girls and young women (AGYW) in Kenya. The research addresses a...

Grant Award Summary The Fogarty International Center awarded Impact Research and Development Organisation (IRDO) a $234,292 Project Grant (CFDA 93.989: International Research and Research Training) effective September 13, 2025, through August 31, 2028, to develop and pilot test a multilevel, community-based intervention addressing pre-exposure prophylaxis (PrEP) stigma among adolescent girls and young women (AGYW) ages 15–24 in western Kenya. The project deliverables include participatory...

This Project Grant award in the amount of $431,712, funded by the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to improve HIV testing among children under five in rural Uganda. The primary goal is to engage with traditional healers to facilitate HIV counseling and testing via oral swab antigen tests for this vulnerable pediatric population. The award supports two key activities: 1) determining barriers and...

Federal Grant Award Summary The University of Iowa received a $1.24 million Project Grant from the Fogarty International Center under the International Research and Research Training program (CFDA 93.989) awarded September 9, 2025, with completion scheduled for August 31, 2028. The award supports adaptation and pilot testing of a multi-level, peer-led HIV prevention and stigma reduction intervention for adolescents in Western Kenya. The project delivers a comprehensive intervention package...

This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $381,487 to the University of Maryland, Baltimore (UMB) to assess the early implementation of long-acting injectable cabotegravir (CAB-LA) pre-exposure prophylaxis (PrEP) among adolescent girls and young women (AGYW) at high risk of HIV acquisition in Zambia. The key objectives are to: 1) Evaluate implementation determinants of CAB-LA...

Federal Project Grant Award Summary Fred Hutchinson Cancer Center received a $500,000 Project Grant award dated September 12, 2025, from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310). The award, scheduled for completion by June 30, 2030, funds a hybrid effectiveness-implementation cluster-randomized controlled trial designed to optimize human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) and...

Federal Grant Award Summary The National Institute of Mental Health (NIMH) under its Mental Health Research Grants program (CFDA 93.242) awarded a Project Grant of $186,142 to the University of California, San Francisco effective May 1, 2026, through April 30, 2031. This five-year research initiative focuses on optimizing the delivery of biomedical HIV prevention interventions for mobile men in fishing communities along Lake Victoria, Kenya. The project addresses critical gaps in HIV...

This $1,272,341 cooperative agreement from the Centers for Disease Control and Prevention will support efforts to promote pre-exposure prophylaxis (PrEP) adherence among men who have sex with men of color. Awarded under the HIV Demonstration, Research, Public and Professional Education Projects program (CFDA 93.941), the University of North Carolina at Chapel Hill will work to develop and test improved HIV prevention strategies from September 2021 through October 2022. A subaward of $250,000...

The Department of State Bureau of African Affairs awarded a $214,992 project grant to Nephak, a division of the National Empowerment Network Of People Living With HIV & Aid, to routinely collect patient and provider level data related to the quality of services provided at the site level in three categories of counties in Kenya. Specifically, under the U.S. President's Emergency Plan for AIDS Relief Programs (PEPFAR, CFDA 19.029), Nephak will collect data in the categories of Evolved,...

This federal Project Grant award of $709,872 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to develop and pilot test a couple-based intervention to address perinatal depression and improve adherence to prevention of mother-to-child transmission (PMTCT) of HIV in Malawi. The key objectives are to: 1) develop a couple-based intervention using problem-solving therapy and content on couple...